<p>Avantor, Inc. (NYSE:AVTR - 獲取免費報告) 的股價在週三交易前跳漲，此前該公司宣佈季度收益好於預期。該股此前收於 $7.86，但開盤價為 $8.50。Avantor 的股票最後交易價格為 $7.92，成交量為 2,179,825 股。</p>
<p>該公司報告本季度每股收益為 $0.17，超出分析師一致預期的 $0.16，超出幅度為 $0.01。該公司本季度的收入為 $15.8 億，而分析師預期為 $15.5 億。Avantor 的淨利潤率為 -8.09%，股本回報率為 10.45%。該公司的收入同比增長 0%。在去年同期，該公司每股收益為 $0.23。</p>
<h2>華爾街分析師觀點</h2>
<p>幾位分析師最近對 AVTR 股票發表了看法。羅伯特·W·貝爾德在 2 月 12 日的研究報告中將 Avantor 的目標價設定為 $11.00。扎克斯研究在 2 月 13 日的研究報告中將 Avantor 的評級從 “持有” 下調至 “強烈賣出”。傑富瑞金融集團在 2 月 12 日的研究報告中重申了 “表現不佳” 的評級，並將 Avantor 的目標價設定為 $8.00。摩根士丹利在 2 月 13 日的報告中將 Avantor 的目標價設定為 $10.00。最後，巴克萊在 4 月 14 日的研究報告中將 Avantor 的目標價從 $8.50 下調至 $7.00，並對該股票給予 “減持” 評級。三位分析師對該股票給予買入評級，九位分析師給予持有評級，三位分析師給予賣出評級。根據 MarketBeat.com 的數據，Avantor 目前的平均評級為 “持有”，共識目標價為 $11.54。</p>
<p><strong>閲讀我們最新的 AVTR 股票分析</strong></p>
<h2>Avantor 內部活動</h2>
<p>在相關消息中，董事 Sanjeev K. Mehra 於 3 月 10 日以每股平均 $8.01 的價格購買了 125,000 股公司的股票，總價值為 $1,001,250.00。交易完成後，該董事直接持有 475,000 股公司的股票，價值約為 $3,804,750。這代表了他們持股比例的 35.71% 增加。該收購在向 SEC 提交的文件中披露，文件可通過 SEC 網站訪問。此外，董事 Gregory L. Summe 於 2 月 12 日以每股平均 $9.40 的價格購買了 100,000 股 Avantor 股票，總價值為 $940,000.00。收購後，該董事持有 400,000 股公司的股票，價值約為 $3,760,000。這筆交易代表了他們持股比例的 33.33% 增加。關於此次購買的 SEC 文件提供了更多信息。過去 90 天內，內部人士購買了價值 $2,399,250 的 275,000 股公司股票。當前 0.28% 的股票由公司內部人士持有。</p>
<h2>機構資金流入和流出</h2>
<p>幾家機構投資者和對沖基金最近買賣了該公司的股票。威靈頓管理集團在第四季度購買了價值約 $268,584,000 的 Avantor 新股份。Greenhaven Associates Inc. 在第三季度購買了價值約 $228,528,000 的 Avantor 新頭寸。弗吉尼亞州倫敦公司在第三季度收購了價值約 $159,669,000 的 Avantor 新股份。摩根士丹利在第四季度將其在 Avantor 的持股增加了 179.4%。摩根士丹利目前持有 17,468,418 股公司的股票，價值 $200,188,000，此前在該期間內又收購了 11,216,565 股。最後，挪威銀行在第四季度購買了價值 $73,322,000 的 Avantor 新股份。機構投資者目前持有該公司 95.08% 的股票。</p>
<h2>Avantor 股票下跌 0.4%</h2>
<p>該公司的債務與股本比率為 0.70，速動比率為 1.18，流動比率為 1.78。該公司的 50 日簡單移動平均線為 $8.19，200 日簡單移動平均線為 $10.53。該股票的市值為 $53.4 億，市盈率為 -10.00，市盈增長比率為 3.13，貝塔值為 1.00。</p>
<h2>關於 Avantor</h2>
<p>(獲取免費報告)</p>
<p>Avantor, Inc NYSE: AVTR 是一家全球性公司，向生物製藥、醫療保健、教育與政府以及先進技術與應用材料行業的客户提供關鍵任務產品和服務。該公司提供支持研究、開發、生產和安全應用的基本解決方案。其產品組合涵蓋從高純度化學品和試劑到生物製品和細胞培養基，以及實驗室設備、耗材和定製製造服務。</p>
<p>Avantor 的產品按兩個主要部門進行組織。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Avantor</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 $1,000 在 Avantor 嗎？</h2>
<p>在你考慮 Avantor 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前進行購買……而 Avantor 並不在名單上。</p>
<p>雖然 Avantor 目前在分析師中獲得 “持有” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

AVTR

紐交所高增長板生物技術指數 ETF - First Trust

生物科技 ETF - VanEck Vectors

<p>Avantor, Inc.（紐約證券交易所代碼：AVTR）在報告季度每股收益為 0.17 美元，超出預期的 0.16 美元后，股價跳漲至 8.50 美元。該公司還報告了 15.8 億美元的收入，超過了預期的 15.5 億美元。分析師對該股票的評級不一，普遍目標價為 11.54 美元。近期內部人士的購買表明對公司的信心，而機構投資者持有 95.08% 的股份。儘管收益表現積極，但該股票仍下跌 0.4%，市值為 53.4 億美元</p>

<p>Avantor, Inc. (NYSE:AVTR - Get Free Report)'s share price gapped up prior to trading on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $7.86, but opened at $8.50. Avantor shares last traded at $7.92, with a volume of 2,179,825 shares trading hands.</p>
<div class="lb-trans"><p>Avantor, Inc. (NYSE:AVTR - 獲取免費報告) 的股價在週三交易前跳漲，此前該公司宣佈季度收益好於預期。該股此前收於 $7.86，但開盤價為 $8.50。Avantor 的股票最後交易價格為 $7.92，成交量為 2,179,825 股。</p>
</div><p>The company reported $0.17 earnings per share for the quarter, topping analysts' consensus estimates of $0.16 by $0.01. The firm had revenue of $1.58 billion during the quarter, compared to analysts' expectations of $1.55 billion. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The firm's revenue was up .0% on a year-over-year basis. During the same period in the prior year, the company earned $0.23 EPS.</p>
<div class="lb-trans"><p>該公司報告本季度每股收益為 $0.17，超出分析師一致預期的 $0.16，超出幅度為 $0.01。該公司本季度的收入為 $15.8 億，而分析師預期為 $15.5 億。Avantor 的淨利潤率為 -8.09%，股本回報率為 10.45%。該公司的收入同比增長 0%。在去年同期，該公司每股收益為 $0.23。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>Several analysts have recently weighed in on AVTR shares. Robert W. Baird set a $11.00 target price on Avantor in a research note on Thursday, February 12th. Zacks Research cut Avantor from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a research note on Friday, February 13th. Jefferies Financial Group restated an &#34;underperform&#34; rating and set a $8.00 price objective on shares of Avantor in a research note on Thursday, February 12th. Morgan Stanley set a $10.00 price objective on Avantor in a report on Friday, February 13th. Finally, Barclays cut their target price on Avantor from $8.50 to $7.00 and set an &#34;underweight&#34; rating on the stock in a research report on Tuesday, April 14th. Three analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company's stock. According to MarketBeat.com, Avantor presently has an average rating of &#34;Hold&#34; and a consensus price target of $11.54.</p>
<div class="lb-trans"><p>幾位分析師最近對 AVTR 股票發表了看法。羅伯特·W·貝爾德在 2 月 12 日的研究報告中將 Avantor 的目標價設定為 $11.00。扎克斯研究在 2 月 13 日的研究報告中將 Avantor 的評級從 “持有” 下調至 “強烈賣出”。傑富瑞金融集團在 2 月 12 日的研究報告中重申了 “表現不佳” 的評級，並將 Avantor 的目標價設定為 $8.00。摩根士丹利在 2 月 13 日的報告中將 Avantor 的目標價設定為 $10.00。最後，巴克萊在 4 月 14 日的研究報告中將 Avantor 的目標價從 $8.50 下調至 $7.00，並對該股票給予 “減持” 評級。三位分析師對該股票給予買入評級，九位分析師給予持有評級，三位分析師給予賣出評級。根據 MarketBeat.com 的數據，Avantor 目前的平均評級為 “持有”，共識目標價為 $11.54。</p>
</div><p><strong>Read Our Latest Stock Analysis on AVTR</strong></p>
<div class="lb-trans"><p><strong>閲讀我們最新的 AVTR 股票分析</strong></p>
</div><h2>Insider Activity at Avantor</h2>
<div class="lb-trans"><h2>Avantor 內部活動</h2>
</div><p>In related news, Director Sanjeev K. Mehra bought 125,000 shares of the company's stock in a transaction on Tuesday, March 10th. The shares were purchased at an average cost of $8.01 per share, with a total value of $1,001,250.00. Following the completion of the transaction, the director directly owned 475,000 shares of the company's stock, valued at approximately $3,804,750. This represents a 35.71% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Gregory L. Summe purchased 100,000 shares of Avantor stock in a transaction dated Thursday, February 12th. The shares were purchased at an average cost of $9.40 per share, with a total value of $940,000.00. Following the acquisition, the director owned 400,000 shares of the company's stock, valued at approximately $3,760,000. This trade represents a 33.33% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased 275,000 shares of company stock worth $2,399,250 in the last 90 days. 0.28% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在相關消息中，董事 Sanjeev K. Mehra 於 3 月 10 日以每股平均 $8.01 的價格購買了 125,000 股公司的股票，總價值為 $1,001,250.00。交易完成後，該董事直接持有 475,000 股公司的股票，價值約為 $3,804,750。這代表了他們持股比例的 35.71% 增加。該收購在向 SEC 提交的文件中披露，文件可通過 SEC 網站訪問。此外，董事 Gregory L. Summe 於 2 月 12 日以每股平均 $9.40 的價格購買了 100,000 股 Avantor 股票，總價值為 $940,000.00。收購後，該董事持有 400,000 股公司的股票，價值約為 $3,760,000。這筆交易代表了他們持股比例的 33.33% 增加。關於此次購買的 SEC 文件提供了更多信息。過去 90 天內，內部人士購買了價值 $2,399,250 的 275,000 股公司股票。當前 0.28% 的股票由公司內部人士持有。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>Several institutional investors and hedge funds have recently bought and sold shares of the company. Wellington Management Group LLP bought a new stake in shares of Avantor during the fourth quarter valued at approximately $268,584,000. Greenhaven Associates Inc. bought a new position in Avantor in the 3rd quarter worth approximately $228,528,000. London Co. of Virginia acquired a new stake in Avantor in the 3rd quarter valued at approximately $159,669,000. Morgan Stanley increased its position in Avantor by 179.4% in the 4th quarter. Morgan Stanley now owns 17,468,418 shares of the company's stock valued at $200,188,000 after acquiring an additional 11,216,565 shares during the period. Finally, Norges Bank bought a new stake in Avantor during the 4th quarter valued at $73,322,000. Institutional investors own 95.08% of the company's stock.</p>
<div class="lb-trans"><p>幾家機構投資者和對沖基金最近買賣了該公司的股票。威靈頓管理集團在第四季度購買了價值約 $268,584,000 的 Avantor 新股份。Greenhaven Associates Inc. 在第三季度購買了價值約 $228,528,000 的 Avantor 新頭寸。弗吉尼亞州倫敦公司在第三季度收購了價值約 $159,669,000 的 Avantor 新股份。摩根士丹利在第四季度將其在 Avantor 的持股增加了 179.4%。摩根士丹利目前持有 17,468,418 股公司的股票，價值 $200,188,000，此前在該期間內又收購了 11,216,565 股。最後，挪威銀行在第四季度購買了價值 $73,322,000 的 Avantor 新股份。機構投資者目前持有該公司 95.08% 的股票。</p>
</div><h2>Avantor Stock Down 0.4%</h2>
<div class="lb-trans"><h2>Avantor 股票下跌 0.4%</h2>
</div><p>The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.18 and a current ratio of 1.78. The firm has a 50 day simple moving average of $8.19 and a two-hundred day simple moving average of $10.53. The stock has a market cap of $5.34 billion, a P/E ratio of -10.00, a P/E/G ratio of 3.13 and a beta of 1.00.</p>
<div class="lb-trans"><p>該公司的債務與股本比率為 0.70，速動比率為 1.18，流動比率為 1.78。該公司的 50 日簡單移動平均線為 $8.19，200 日簡單移動平均線為 $10.53。該股票的市值為 $53.4 億，市盈率為 -10.00，市盈增長比率為 3.13，貝塔值為 1.00。</p>
</div><h2>About Avantor</h2>
<div class="lb-trans"><h2>關於 Avantor</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Avantor, Inc NYSE: AVTR is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education &amp; government, and advanced technologies &amp; applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.</p>
<div class="lb-trans"><p>Avantor, Inc NYSE: AVTR 是一家全球性公司，向生物製藥、醫療保健、教育與政府以及先進技術與應用材料行業的客户提供關鍵任務產品和服務。該公司提供支持研究、開發、生產和安全應用的基本解決方案。其產品組合涵蓋從高純度化學品和試劑到生物製品和細胞培養基，以及實驗室設備、耗材和定製製造服務。</p>
</div><p>Avantor's offerings are organized across two primary segments.</p>
<div class="lb-trans"><p>Avantor 的產品按兩個主要部門進行組織。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Avantor</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Avantor</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Avantor Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 $1,000 在 Avantor 嗎？</h2>
</div><p>Before you consider Avantor, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Avantor 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前進行購買……而 Avantor 並不在名單上。</p>
</div><p>While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Avantor 目前在分析師中獲得 “持有” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Avantor (NYSE:AVTR) Shares Gap Up  on Strong Earnings

Market Beat

Avantor

美國醫藥設備 ETF - iShares

標普生物技術 3 倍做多 - Direxion

2 倍做多納斯達克生物技術 ETF - ProShares

動態生物技術與基因組 ETF - Invesco

標普健康醫療設備 ETF - SPDR

標普生物技術 ETF - SPDR

納斯達克生物科技指數 ETF - iShares Nasdaq

醫藥突破 ETF - ALPS

Jefferies Financial

摩根士丹利

巴克萊銀行

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

Avantor（紐交所代碼：AVTR）因強勁的業績而股價跳空高開